针对MAFLD的机制和治疗策略 针对TLR4信号通路
Guanghui Ren1, Changchuan Bai2, Sitong Yi3
1Department of Infectious Disease, Liver Disease Center of Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, China, 18842664480@163.com.
Journal of innate immunity
|December 21, 2023
概括
与代谢相关的脂肪肝疾病 (MAFLD) 涉及复杂的机制,与托尔类受体4 (TLR4) 信号驱动进展. 准TLR4为MAFLD提供了潜在的治疗策略.
科学领域:
- 肝病学和免疫学研究.
- 专注于代谢和炎症性肝脏疾病.
背景情况:
- 代谢相关的脂肪肝疾病 (MAFLD) 是一种普遍存在的慢性肝病,其原因复杂,多因素.
- 目前对MAFLD的治疗选择有限.
- 收费类受体 (TLRs),特别是TLR4,通过激活先天免疫反应,与MAFLD病原体有关.
研究的目的:
- 审查TLR4信号通路在MAFLD进展中的重要作用.
- 探索TLR4和关键MAFLD机制 (如脂质代谢,胰岛素抵抗,氧化应激和肠道微生物群失调) 之间的联系.
- 突出针对TLR4进行MAFLD治疗的潜在治疗策略.
主要方法:
- 文献综述总结了MAFLD中TLR4信号传导的当前研究.
- 分析TLR4对MAFLD代谢障碍,炎症和肠道健康的影响.
- 针对TLR4.4的潜在治疗干预措施的识别和分类.
主要成果:
- 通过促进脂质过氧化,炎症,胰岛素抵抗和肠道失调症,TLR4信号加剧MAFLD.
- TLR4通路与肥胖和瘦胖的MAFLD表型有关.
- 抑制TLR4信号传递是缓解MAFLD的一个有希望的方法.
结论:
- TLR4是MAFLD病变的关键调解者,影响脂质积累,胰岛素抵抗,氧化应激和免疫激活.
- 准TLR4信号通路为MAFLD提供了一个可行的治疗途径.
- 潜在的治疗方法包括植物提取物,传统药物,益生菌,药品和生活方式改变.
相关概念视频
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Inflammatory Bowel Disease IV: Pharmacological Management
128
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
128
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
141
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
141
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K


